Division of Biomedical Technology534
Division of Biomedical Technology aims to improve quality of human life through the convergence of basic, applied life science and biomaterial technology development. We will conduct research on disease-related mechanisms and therapeutic targets based on the companion indicators, and develop molecular and non-molecular diagnostic indicators including drug-susceptibility. Functional biomaterials and bioplastics using biocompatible polymers are under development and a variety of microplastic models are studied to test its ecological and human health hazards. We aim to contribute to the improvement of national health and quality of life as part of the national science and technology policy related to biomedical research.
DGIST Division of Biomedical Technology Homepage
DGIST Division of Biomedical Technology Homepage
Subject
- EXPRESSION 26
- PROTEIN 19
- CELLS 16
- NANOPARTICLES 16
- APOPTOSIS 15
- Article 15
- GROWTH 15
- ACTIVATION 14
- FABRICATION 14
- MODEL 12
Date issued
- 2020 - 2026 176
- 2010 - 2019 182
- 2006 - 2009 24
Co-Author(s)
Related Keyword
Recent Submissions
- 코로나바이러스 감염증 COVID-19 치료용 펩타이드 및 이의 용도
- CARS 현미경 및 이의 제어 방법
- Effect of JIN-A02, a Novel 4Th-Generation EGFR-TKI, on Multiple EGFR Mutations in Comparison With 3Rd-Generation EGFR-TKIs
- Metixene hydrochloride hydrate mitigates kidney tubulointerstitial fibrosis by inhibiting Smad3 phosphorylation
- 아스타잔틴 분비능을 갖는 플라노코쿠스 속 균주 및 이의 용도
